Back to Market Feed

This NDC is on FDA's drug shortage list (posted Feb 20, 2018)

Product Information

BUPIVACAINE 0.5% VIAL is a generic product labeled by Somerset Therapeutics, LLC, priced at $0.0860 per ML under NDC 70069075301. Its NADAC has been published 92 times since Nov 20, 2024.

FDA first approved this application on Nov 20, 2023. Its Orange Book therapeutic-equivalence code is AP.

BUPIVACAINE 0.5% VIAL

Bupivacaine hydrochloride
$0.0860per ML

Strength

5 mg/mL

NDC

70069075301

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INFILTRATION; PERINEURAL

Effective Date

4/22/2026

Active Ingredients

BUPIVACAINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA217792

FDA Approved

11/20/2023

TE Code

AP

On Market Since

11/27/2023

Pharmacological Classes

Amide Local Anesthetic
Amides
Local Anesthesia

Price Statistics

The NADAC for BUPIVACAINE 0.5% VIAL has been published 92 times since Nov 20, 2024, and over the history we have for it it has risen 17.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0860 per ML
All-time high$0.0860 (Aug 19, 2026)
All-time low$0.0701 (Mar 19, 2025)
52-week high$0.0860
52-week low$0.0778
Median price$0.0785
Average price$0.0788
Largest weekly change+6.8% (Jun 18, 2025)
Weeks tracked92
Tracking sinceNov 20, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.6%

1Y

+10.4%

3Y

N/A

5Y

N/A

All

+17.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bupivacaine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0280
per GM
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
60687060365•American Health Packaging
$0.0385
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
50268072815•AvPAK
$0.0397
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
53746027105•Amneal Pharmaceuticals of New York LLC
$0.0397
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023201•Rising Pharma Holdings Inc.
$0.0397
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023205•Rising Pharma Holdings Inc.
$0.0397
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089718•Chartwell RX LLC
$0.0397
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089790•Chartwell RX LLC
$0.0397
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65162027110•Amneal Pharmaceuticals LLC
$0.0397
per EA

Frequently asked questions

What is the NADAC price of BUPIVACAINE 0.5% VIAL?

The current National Average Drug Acquisition Cost (NADAC) for BUPIVACAINE 0.5% VIAL, manufactured by Somerset Therapeutics, LLC, is $0.0860 per ML (NDC 70069075301), effective Aug 19, 2026.

How has the price of BUPIVACAINE 0.5% VIAL changed over time?

Over the history we have for it, the NADAC for BUPIVACAINE 0.5% VIAL has risen 17.0%. It has been tracked across 92 weekly CMS publications since Nov 20, 2024.

What are the highest and lowest recorded NADAC prices for BUPIVACAINE 0.5% VIAL?

Since Nov 20, 2024, the NADAC for BUPIVACAINE 0.5% VIAL has ranged from a low of $0.0701 (Mar 19, 2025) to a high of $0.0860 (Aug 19, 2026), with a median of $0.0785 per ML.

Are there cheaper alternatives to BUPIVACAINE 0.5% VIAL?

No other NADAC-published product currently shares the active ingredient and strength of BUPIVACAINE 0.5% VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BUPIVACAINE 0.5% VIAL?

BUPIVACAINE 0.5% VIAL (NDC 70069075301) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.

Is BUPIVACAINE 0.5% VIAL in shortage?

Yes — NDC 70069075301 is currently listed in FDA's drug shortage database (posted Feb 20, 2018).